APP and neurodegenerative disease: While in the work reported here we found no change in brain 7B2 levels as a function of APP transgene status, three proteomics studies have identified 7B2 in CSF taken from patients with neurodegenerative diseases involving protein aggregation; in two of these, 7B2 levels were increased in patient CSF33–35.